VALN CIK: 1836564

Valneva SE

  • France
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions EUR
FY21:
586
FY22:
425
FY23:
263
FY24:
299
FY25:
223
(positive)
Change from FY21 to FY25
millions EUR
FY21:
232
FY22:
197
FY23:
197
FY24:
201
FY25:
176
Total assets
Change from FY21 to FY25
millions EUR
FY21:
817
FY22:
621
FY23:
460
FY24:
500
FY25:
399

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions EUR
FY21:
369
FY22:
277
FY23:
159
FY24:
115
FY25:
93.3
(negative)
Change from FY21 to FY25
millions EUR
FY21:
278
FY22:
124
FY23:
173
FY24:
204
FY25:
199
(positive)
Change from FY21 to FY25
millions EUR
FY21:
171
FY22:
220
FY23:
128
FY24:
181
FY25:
106
Total liabilities & equity
Change from FY21 to FY25
millions EUR
FY21:
817
FY22:
621
FY23:
460
FY24:
500
FY25:
399

All amounts in millions EUR Data source:SEC EDGAR